Following injury, tissue factor (TF)-bearing cells are exposed to the blood, triggering blood clot formation. Blood clots are stabilized by a web-like network of fibrin, which protects the clot from the rigors of flowing blood. Fibrin also has immunological functions during infection and contributes to wound healing. Studies have shown that abnormalities in the formation or quality (structure and/or stability) of the fibrin network are an established, independent risk factor for abnormal blood clots (thrombosis and/or bleeding). We and others have shown that different cells determine fibrin quality via their procoagulant activity and receptor expression. Interestingly, both cellular procoagulant activity and receptors produce fibrin that is denser and more stable near the cell than further away from the cell surface. We hypothesize that the spatial location of thrombin generation influences clot structure and stability. We will use laser scanning confocal microscopy to characterize activities that regulate fibrin clot structure proximal and distal to the site of clotting initiation. We will specifically investigate the roles of cell stimulation, cellular and circulating tissue factor, soluble clotting factors, and cell receptors in determining clot structure. We will use passive and magnetically-driven microbead techniques and microscopy to examine how vascular cells modulate fibrin network permeability, mechanical strength and resistance to fibrinolysis. Finally, we will use transmission electron microscopy to compare fibrin structure in clots formed under different shear rates on freshly-excised human vessels. We anticipate our data will show how different hemostatic and prothrombotic mechanisms contribute to clot structure and stability in static and low shear conditions. These mechanisms may be specific targets for preventing intravascular thrombosis and/or embolism.
Inappropriate blood clot formation (thrombosis) is the leading cause of death and disability in the Western world. Understanding the mechanisms leading to thrombosis is critical in order to develop approaches for preventing this devastating disease.
| Foley, Jonathan H; Walton, Bethany L; Aleman, Maria M et al. (2016) Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin. EBioMedicine 5:175-82 |
| Byrnes, James R; Duval, Cédric; Wang, Yiming et al. (2015) Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin ?-chain crosslinking. Blood 126:1940-8 |
| Aleman, Maria M; Holle, Lori A; Stember, Katherine G et al. (2015) Cystamine preparations exhibit anticoagulant activity. PLoS One 10:e0124448 |
| Gebhart, J; Laczkovics, C; Posch, F et al. (2015) Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause. Ann Hematol 94:1301-10 |
| Krebs, C R; Li, Ling; Wolberg, Alisa S et al. (2015) A portable blood plasma clot micro-elastometry device based on resonant acoustic spectroscopy. Rev Sci Instrum 86:075005 |
| Amin, Chirag; Adam, Soheir; Mooberry, Micah J et al. (2015) Coagulation activation in sickle cell trait: an exploratory study. Br J Haematol 171:638-46 |
| Zucker, M; Seligsohn, U; Salomon, O et al. (2014) Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost 12:1121-30 |
| Aleman, Maria M; Walton, Bethany L; Byrnes, James R et al. (2014) Fibrinogen and red blood cells in venous thrombosis. Thromb Res 133 Suppl 1:S38-40 |
| Aleman, Maria M; Byrnes, James R; Wang, Jian-Guo et al. (2014) Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest 124:3590-600 |
| Walton, B L; Getz, T M; Bergmeier, W et al. (2014) The fibrinogen ?A/?' isoform does not promote acute arterial thrombosis in mice. J Thromb Haemost 12:680-9 |
Showing the most recent 10 out of 42 publications
